Sophie Stotz

Sophie Stotz is a Postdoctoral Researcher (Research Fellow) in the Department of Drug Design and Pharmacology at the Faculty of Health and Medical Sciences, University of Copenhagen. She works under Prof. Herth's supervision, specializing in translational radiopharmaceutical research for disease detection and treatment with emphasis on neuroscience applications.

Her academic qualifications include:

• Dr. rer. nat. in Biochemistry (awarded November 28, 2023)
• M.Sc. in Biochemistry (awarded March 1, 2019)
• B.Sc. in Biochemistry (awarded October 19, 2015)

Dr. Stotz's research integrates in vitro and in vivo methodologies to develop radiopharmaceuticals for clinical translation. Her expertise spans cancer imaging (advancing reporter gene imaging and tumor-detection radiotracers to preclinical stages) and neuroscience (pioneering pretargeted imaging techniques for brain disorders). She maintains active engagement with international imaging societies and prioritizes training the next generation of scientists through mentorship and teaching.

Analysis of her 2024-2025 publications reveals dual research thrusts: neuroimaging (CaMKIIα targeting, BBB-penetrating tetrazines) and oncology (PARP inhibitor radiotracers for HR-deficient cancers). These works demonstrate sophisticated integration of radiochemistry, molecular biology, and preclinical validation, with strong emphasis on improving target-to-background contrast and translational readiness.

Dr. Stotz actively contributes to scientific discourse through conference presentations and peer-reviewed publications while maintaining ORCID visibility (0000-0003-4020-1088). Her collaborative network spans Germany, Denmark, and international consortia in nuclear medicine.